308 related articles for article (PubMed ID: 23929932)
1. Effect of renin-angiotensin system blockade on soluble Klotho in patients with type 2 diabetes, systolic hypertension, and albuminuria.
Karalliedde J; Maltese G; Hill B; Viberti G; Gnudi L
Clin J Am Soc Nephrol; 2013 Nov; 8(11):1899-905. PubMed ID: 23929932
[TBL] [Abstract][Full Text] [Related]
2. Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure-independent effect.
Viberti G; Wheeldon NM;
Circulation; 2002 Aug; 106(6):672-8. PubMed ID: 12163426
[TBL] [Abstract][Full Text] [Related]
3. Combined therapy with renin-angiotensin system and calcium channel blockers in type 2 diabetic hypertensive patients with proteinuria: effects on soluble TWEAK, PTX3, and flow-mediated dilation.
Yilmaz MI; Carrero JJ; Martín-Ventura JL; Sonmez A; Saglam M; Celik T; Yaman H; Yenicesu M; Eyileten T; Moreno JA; Egido J; Blanco-Colio LM
Clin J Am Soc Nephrol; 2010 Jul; 5(7):1174-81. PubMed ID: 20430947
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the efficacy and safety profiles of two fixed-dose combinations of antihypertensive agents, amlodipine/benazepril versus valsartan/hydrochlorothiazide, in patients with type 2 diabetes mellitus and hypertension: a 16-week, multicenter, randomized, double-blind, noninferiority study.
Lee IT; Hung YJ; Chen JF; Wang CY; Lee WJ; Sheu WH
Clin Ther; 2012 Aug; 34(8):1735-50. PubMed ID: 22784975
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin receptor blocker/diuretic combination preserves insulin responses in obese hypertensives.
Sowers JR; Raij L; Jialal I; Egan BM; Ofili EO; Samuel R; Zappe DH; Purkayastha D; Deedwania PC
J Hypertens; 2010 Aug; 28(8):1761-9. PubMed ID: 20498618
[TBL] [Abstract][Full Text] [Related]
6. Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups.
Assaad-Khalil SH; Najem R; Sison J; Kitchlew AR; Cho B; Ueng KC; DiTommaso S; Shete A
Vasc Health Risk Manag; 2015; 11():71-8. PubMed ID: 25653536
[TBL] [Abstract][Full Text] [Related]
7. Antiproteinuric effects of angiotensin receptor blockers: telmisartan versus valsartan in hypertensive patients with type 2 diabetes mellitus and overt nephropathy.
Galle J; Schwedhelm E; Pinnetti S; Böger RH; Wanner C;
Nephrol Dial Transplant; 2008 Oct; 23(10):3174-83. PubMed ID: 18450829
[TBL] [Abstract][Full Text] [Related]
8. Randomized study to compare valsartan +/- HCTZ versus amlodipine +/- HCTZ strategies to maximize blood pressure control.
Zappe D; Papst CC; Ferber P;
Vasc Health Risk Manag; 2009; 5():883-92. PubMed ID: 19898644
[TBL] [Abstract][Full Text] [Related]
9. Valsartan improves arterial stiffness in type 2 diabetes independently of blood pressure lowering.
Karalliedde J; Smith A; DeAngelis L; Mirenda V; Kandra A; Botha J; Ferber P; Viberti G
Hypertension; 2008 Jun; 51(6):1617-23. PubMed ID: 18426991
[TBL] [Abstract][Full Text] [Related]
10. A noninferiority comparison of valsartan/hydrochlorothiazide combination versus amlodipine in black hypertensives.
Weir MR; Ferdinand KC; Flack JM; Jamerson KA; Daley W; Zelenkofske S
Hypertension; 2005 Sep; 46(3):508-13. PubMed ID: 16116046
[TBL] [Abstract][Full Text] [Related]
11. Changes in aortic pulse wave velocity in hypertensive postmenopausal women: comparison between a calcium channel blocker vs angiotensin receptor blocker regimen.
Hayoz D; Zappe DH; Meyer MA; Baek I; Kandra A; Joly MP; Mazzolai L; Haesler E; Periard D
J Clin Hypertens (Greenwich); 2012 Nov; 14(11):773-8. PubMed ID: 23126349
[TBL] [Abstract][Full Text] [Related]
12. Effects of high sodium intake and diuretics on the circadian rhythm of blood pressure in type 2 diabetic patients treated with an angiotensin II receptor blocker.
Uzu T; Sakaguchi M; Yokomaku Y; Kume S; Kanasaki M; Isshiki K; Araki SI; Sugiomoto T; Koya D; Haneda M; Kashiwagi A
Clin Exp Nephrol; 2009 Aug; 13(4):300-306. PubMed ID: 19255824
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, active-controlled, parallel-group comparison of valsartan and amlodipine in the treatment of isolated systolic hypertension in elderly patients: the Val-Syst study.
Malacco E; Varì N; Capuano V; Spagnuolo V; Borgnino C; Palatini P;
Clin Ther; 2003 Nov; 25(11):2765-80. PubMed ID: 14693303
[TBL] [Abstract][Full Text] [Related]
14. Additive effects of cilnidipine and angiotensin II receptor blocker in preventing the progression of diabetic nephropathy in diabetic spontaneously hypertensive rats.
Aritomi S; Niinuma K; Ogawa T; Konda T; Nitta K
Clin Exp Nephrol; 2013 Feb; 17(1):41-50. PubMed ID: 23011292
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of the combination of amlodipine and valsartan in patients with hypertension uncontrolled with previous monotherapy: the Exforge in Failure after Single Therapy (EX-FAST) study.
Allemann Y; Fraile B; Lambert M; Barbier M; Ferber P; Izzo JL
J Clin Hypertens (Greenwich); 2008 Mar; 10(3):185-94. PubMed ID: 18326958
[TBL] [Abstract][Full Text] [Related]
16. Effects of CPAP on "vascular" risk factors in patients with obstructive sleep apnea and arterial hypertension.
Litvin AY; Sukmarova ZN; Elfimova EM; Aksenova AV; Galitsin PV; Rogoza AN; Chazova IE
Vasc Health Risk Manag; 2013; 9():229-35. PubMed ID: 23690688
[TBL] [Abstract][Full Text] [Related]
17. Comparison between valsartan and valsartan plus cilnidipine in type II diabetics with normo- and microalbuminuria.
Katayama K; Nomura S; Ishikawa H; Murata T; Koyabu S; Nakano T
Kidney Int; 2006 Jul; 70(1):151-6. PubMed ID: 16710356
[TBL] [Abstract][Full Text] [Related]
18. Probucol in Albuminuric Type 2 Diabetes Mellitus Patients on Renin-Angiotensin System Blockade: A 16-Week, Randomized, Double-Blind, Placebo-Controlled Trial.
Jin SM; Han KA; Yu JM; Sohn TS; Choi SH; Chung CH; Park IeB; Rhee EJ; Baik SH; Park TS; Lee IK; Ko SH; Hwang YC; Cha BS; Lee HW; Nam MS; Lee MK
Arterioscler Thromb Vasc Biol; 2016 Oct; 36(10):2108-14. PubMed ID: 27493100
[TBL] [Abstract][Full Text] [Related]
19. Impact of renin-angiotensin system inhibition on microalbuminuria in type 2 diabetes: a post hoc analysis of the Shiga Microalbuminuria Reduction Trial (SMART).
; Uzu T; Sawaguchi M; Maegawa H; Kashiwagi A
Hypertens Res; 2008 Jun; 31(6):1171-6. PubMed ID: 18716365
[TBL] [Abstract][Full Text] [Related]
20. Disparate effects of angiotensin II antagonists and calcium channel blockers on albuminuria in experimental diabetes and hypertension: potential role of nephrin.
Davis BJ; Cao Z; de Gasparo M; Kawachi H; Cooper ME; Allen TJ
J Hypertens; 2003 Jan; 21(1):209-16. PubMed ID: 12544453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
